News

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment of its first COVID-19 patient in the Company's ongoing Phase 3 clinical trial of AR-301,...

Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19. The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...

Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto Bio-Pharma Services, have entered a development collaboration to evaluate AJICAP, a site-specific conjugation technology offered by Aji Bio-Pharma for the development of TRIObody Drug...

Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at additional hospitals across...

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future. Following the drastic social distancing measures implemented across the world, Inspirata announced its COVID-19 Free Remote Pathology Initiative in March, which allows healthcare institutions...

MedPharm, a leading clinical development organization in topical and transdermal drug delivery, has expanded its innovative testing models to support pharmaceutical development programs targeting Coronavirus treatments. These models allow companies to assess therapeutic effectiveness in nasal, airway (bronchial), and...

ARTES Biotechnology, a biotech company specializing in process development for recombinant vaccines, entered development of SARS-CoV-2 vaccine candidates based on its virus-like particle (VLP) based platform technologies METAVAX and SplitCore. METAVAX is a platform for the development of vaccines built...